Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Motor Control Exercises and Myofascial Release Technique on Muscle Strength, Pain Threshold, and Muscle Activation Pattern in Greater Trochanteric Pain Syndrome

NCT07936604 is registered in ClinicalTrials.gov with Harran University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07936604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Motor Control Exercises and Myofascial Release Technique on Muscle Strength, Pain Threshold, and Muscle Activation Pattern in Greater Trochanteric Pain Syndrome
Lead sponsor
Harran University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 30, 2026
Completion date
December 31, 2026
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

greater trochanteric pain syndrome

Arms

As registered; 3 arms.

  • Motor Control Exercise + Myofascial Release ExperimentalMotor Control Exercise + Myofascial Release

    Participants will receive a motor control exercise program combined with myofascial release techniques for 8 weeks.

  • Motor Control Exercise Active comparatorMotor Control Exercise

    Participants will receive a motor control exercise program for 8 weeks.

  • Home Exercise Program Active comparatorHome Exercise Program

    Participants will receive a home-based motor control exercise program in brochure format for 8 weeks.

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Short-Form McGill Pain Questionnaire -Pain Rating Index Baseline and 8 weeks after intervention

    Pain characteristics and severity will be assessed using the 15-item Pain Rating Index of the Short-Form McGill Pain Questionnaire (SF-MPQ). Each item is scored from 0 (none) to 3 (severe), resulting in a total score ranging from 0 to 45. Higher scores indicate greater pain severity and a worse outcome.

  • Short-Form McGill Pain Questionnaire - Present Pain Intensity Baseline and 8 weeks after intervention

    Current pain intensity will be assessed using the Present Pain Intensity (PPI) component of the Short-Form McGill Pain Questionnaire (SF-MPQ). Scores range from 0 (no pain) to 5 (excruciating pain), with higher scores indicating greater current pain intensity and a worse outcome.

  • Short-Form McGill Pain Questionnaire - Visual Analog Scale Baseline and 8 weeks after intervention

    Pain intensity will be assessed using the Visual Analog Scale (VAS) included in the Short-Form McGill Pain Questionnaire (SF-MPQ). The scale ranges from 0 to 10 mm, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and a worse outcome.

Lead sponsor's other trials

Harran University, most recent start first.